Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion
- 2 March 1988
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 115 (3), 499-504
- https://doi.org/10.1016/0002-8703(88)90796-x
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Prostacyclin infusion in patients with acute myocardial infarction.Heart, 1985
- Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarctionJournal of the American College of Cardiology, 1983
- PGI2 Prevents Ischemia-Induced Alterations in Cardiac Catecholamines Without Influencing Nerve-Stimulation-Induced Catecholamine Release in Nonischemic ConditionsJournal of Cardiovascular Pharmacology, 1982
- Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs.Circulation Research, 1981
- Studies on the protective effect of prostacyclin in acute myocardial ischemiaEuropean Journal of Pharmacology, 1979
- Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial IschemiaScience, 1978
- Synthesis and stereochemistry of prostacyclin and synthesis of 6-ketoprostaglandin F1.alpha.Journal of the American Chemical Society, 1977
- Estimation of Infarct Size in Man and its Relation to PrognosisCirculation, 1972
- Myocardial Changes Associated with Cardiogenic ShockNew England Journal of Medicine, 1971
- Factors Influencing Infarct Size Following Experimental Coronary Artery OcclusionsCirculation, 1971